Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. de Castro · SciRah

Researcher profile · Semantic Scholar

J. de Castro

Share profile

J. de Castro — researcher profile on SciRah

h-index: 40
Works: 268
Citations: 13K

Most-cited papers

Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.
M. Provencio, E. Nadal, J. González-Larriba, A. Martínez-Martí +26 more
2023New England Journal of Medicine405 citations Open access
Semantic Scholar
Effect of the COVID-19 pandemic on cancer treatment and research
K. Saini, B. de las Heras, J. de Castro, R. Venkitaraman +7 more
2020The Lancet Haematology124 citations Open access
Semantic Scholar
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
M. González-Cao, T. Morán, J. Dalmau, J. García-Corbacho +21 more
2020JAMA Oncology101 citations Open access
Semantic Scholar
Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial
M. Provencio, E. Nadal, A. Insa, Rosario García Campelo +19 more
2024The Lancet Oncology89 citations Open access
Semantic Scholar
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.
R. Soo, Jy Han, U. Dafni, B. Cho +25 more
2021Annals of Oncology86 citations Open access
Semantic Scholar
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)
E. Nadal, D. Rodríguez-Abreu, M. Simó, B. Massutí +14 more
2023Journal of Clinical Oncology79 citations Open access
Semantic Scholar
Randomized Open-Label Controlled Study of Cancer Vaccine OSE2101 Versus Chemotherapy in HLA-A2-positive Patients with Advanced Non-Small Cell Lung Cancer with Resistance to Immunotherapy: ATALANTE-1.
B. Besse, E. Felip, R. Campelo, M. Cobo +64 more
2023Annals of Oncology76 citations Open access
Semantic Scholar
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
J. Zugazagoitia, Israel Ramos, J. M. Trigo, Magda Palka +18 more
2019Annals of Oncology72 citations Open access
Semantic Scholar
New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
D. Isla, M. Lozano, L. Paz-Ares, C. Salas +6 more
2022Clinical and Translational Oncology47 citations Open access
Semantic Scholar
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: the ROSING Study.
E. Conde, S. Hernandez, R. Martínez, B. Angulo +48 more
2019Journal of Thoracic Oncology47 citations Open access
Semantic Scholar
Priorities in Cardio-Oncology Basic and Translational Science
Fadi N. Salloum, C. Tocchetti, P. Ameri, H. Ardehali +34 more
2023JACC CardioOncology45 citations Open access
Semantic Scholar
Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells
L. Aguirre, Karla Montalbán-Hernández, J. Avendaño-Ortiz, E. Marín +36 more
2020Oncoimmunology41 citations Open access
Semantic Scholar
Low-Dose Radiation Therapy in the Management of Coronavirus Disease 2019 (COVID-19) Pneumonia (LOWRAD-Cov19): Preliminary Report
N. Sanmamed, P. Alcantara, E. Cerezo, M. Gaztañaga +13 more
2020International Journal of Radiation Oncology, Biology, Physics41 citations Open access
Semantic Scholar
Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer
J. Wolf, Å. Helland, I. Oh, M. Migliorino +11 more
2022ESMO Open37 citations Open access
Semantic Scholar
Genomic profiling in non-small-cell lung cancer in young patients. A systematic review
D. Viñal, D. Martínez, O. Higuera, J. de Castro
2021ESMO Open36 citations Open access
Semantic Scholar
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
K. Saini, C. Lanza, Marco Romano, E. de Azambuja +9 more
2020British Journal of Cancer34 citations Open access
Semantic Scholar
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients.
J. Remon, N. Girard, S. Novello, J. de Castro +8 more
2021Clinical Lung Cancer31 citations Open access
Semantic Scholar
Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapy
D. Viñal, L. Gutiérrez-Sainz, D. Martínez, J. Garcia-Cuesta +10 more
2020Clinical and Translational Oncology25 citations
Semantic Scholar
Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance.
J. Zugazagoitia, A. Gómez-Rueda, E. Jantus-Lewintre, D. Isla +15 more
2019Lung Cancer22 citations
Semantic Scholar
Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management
R. Rosas-Alonso, Julián Colmenarejo-Fernandez, O. Pernía, M. Burdiel +17 more
2024Scientific Reports21 citations Open access
Semantic Scholar
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
E. Arriola, M. González-Cao, M. Dómine, J. de Castro +8 more
2022Oncology and Therapy21 citations Open access
Semantic Scholar
OA20.02 Pre-Treatment Levels of ctDNA for Long-Term Survival Prediction in Stage IIIA NSCLC Treated With Neoadjuvant Chemo-Immunotherapy
A. Romero, E. Nadal, R. Serna, A. Insa +23 more
2021Journal of Thoracic Oncology21 citations Open access
Semantic Scholar
Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer
M. Molina-Alejandre, F. Perea, V. Calvo, C. Martínez-Toledo +23 more
2024Journal for ImmunoTherapy of Cancer20 citations Open access
Semantic Scholar
Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challenges.
X. Mielgo-Rubio, Margarita Martín, J. Remon, O. Higuera +9 more
2021Future Oncology18 citations
Semantic Scholar
Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients
R. Rosas-Alonso, Julián Colmenarejo-Fernandez, Olga Pernía, C. Rodríguez-Antolín +9 more
2020Clinical Epigenetics18 citations Open access
Semantic Scholar
Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer
Edurne Arriola, J. de Castro, R. García-Campelo, Beatriz Bernardez +12 more
2024Clinical drug investigation17 citations Open access
Semantic Scholar
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms
K. Saini, B. de las Heras, R. Plummer, V. Moreno +23 more
2020JCO Global Oncology17 citations Open access
Semantic Scholar
Phase II study of durvalumab (MEDI4736) in cancer patients HIV-1-infected.
M. González-Cao, T. Morán, J. Dalmau, J. García-Corbacho +16 more
2019Journal of Clinical Oncology17 citations
Semantic Scholar
Spatially preserved multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage small cell lung cancer.
Melina Peressini, R. García-Campelo, Bartomeu Massutí, C. Martí +39 more
2024Clinical Cancer Research15 citations
Semantic Scholar
Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial.
J. Remon, P. Bironzo, Nicolas Girard, L. Bigay-Game +16 more
2025The Lancet Oncology14 citations Open access
Semantic Scholar
Hypermethylation of Anti-oncogenic MicroRNA 7 is Increased in Emphysema Patients.
R. Rosas-Alonso, R. Galera, Joan José Sánchez-Pascuala, R. Casitas +8 more
2019Archivos de Bronconeumologia14 citations
Semantic Scholar
Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC—a systematic review and meta-analysis
U. Dafni, R. Soo, S. Peters, Z. Tsourti +17 more
2022ESMO Open13 citations Open access
Semantic Scholar
A Novel Role for the Tumor Suppressor Gene ITF2 in Lung Tumorigenesis and Chemotherapy Response
Olga Pernía, A. Sastre-Perona, C. Rodríguez-Antolín, Álvaro García-Guede +12 more
202013 citations Open access
Semantic Scholar
Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus
D. Isla, J. de Castro, R. García-Campelo, P. Lianes +4 more
2019Clinical and Translational Oncology13 citations Open access
Semantic Scholar
RET Fusion Testing in Patients With NSCLC: The RETING Study
Esther Conde, S. Hernandez, J. L. Rodríguez Carrillo, R. Martínez +36 more
2024JTO Clinical and Research Reports11 citations Open access
Semantic Scholar
OA20.01 Long Term Survival in Operable Stage Iiia Nsclc Patients Treated With Neoadjuvant Nivolumab Plus Chemotherapy - Nadim Study
M. Provencio, E. Nadal, A. Insa, M. Garcia Campelo +24 more
2021Journal of Thoracic Oncology11 citations Open access
Semantic Scholar
Low-dose Radiation Therapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19). Final results of a prospective phase I–II trial
N. Sanmamed, P. Alcantara, Sara Gómez, A. Bustos +13 more
2022Radiotherapy and Oncology10 citations Open access
Semantic Scholar
Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers
X. Mielgo-Rubio, V. Calvo, J. Luna, J. Remon +10 more
2020Cancers10 citations Open access
Semantic Scholar
miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients
C. Rodríguez-Antolín, Laura Felguera-Selas, Olga Pernía, O. Vera +5 more
2019Cell & Bioscience10 citations Open access
Semantic Scholar
BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.
M. Provencio, Lucía Robado de Lope, R. Serna-Blasco, Ernest Nadal +31 more
2024Lung Cancer9 citations Open access
Semantic Scholar
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
Aylen Vanessa Ospina, Sergio Bolufer Nadal, J. L. Campo-Cañaveral de la Cruz, J. González Larriba +25 more
2024Clinical and Translational Oncology8 citations Open access
Semantic Scholar
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain
J. de Castro, A. Insa, R. Collado-Borrell, V. Escudero-Vilaplana +6 more
2023BMC Pulmonary Medicine8 citations Open access
Semantic Scholar
MiR-151a: a robust endogenous control for normalizing small extracellular vesicle cargo in human cancer
M. Burdiel, J. Jiménez, C. Rodríguez-Antolín, Álvaro García-Guede +14 more
2023Biomarker Research8 citations Open access
Semantic Scholar
Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1
V. Escudero-Vilaplana, R. Collado-Borrell, J. de Castro, A. Insa +7 more
2023Journal of Medical Economics7 citations Open access
Semantic Scholar
A phase III clinical trial of adjuvant chemotherapy versus chemoimmunotherapy for stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) patients nadim-adjuvant: New adjuvant trial of chemotherapy versus chemoimmunotherapy.
V. Calvo, M. Dómine, I. Sullivan, J. González-Larriba +16 more
20217 citations
Semantic Scholar
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study
E. Jantus-Lewintre, Bartomeu Massutí Sureda, J. González Larriba, D. Rodríguez-Abreu +19 more
2021Frontiers in Oncology7 citations Open access
Semantic Scholar
Novel SLC12A2‐ROS1 Fusion in Non‐Small Cell Lung Cancer with a Significant Response to Crizotinib: The Importance of Choosing the Appropriate Next‐Generation Sequencing Assay
C. Rodríguez-Antolín, R. Rosas-Alonso, P. Cruz, O. Higuera +7 more
2021The Oncologist7 citations Open access
Semantic Scholar
Sequential blinded treatment decisions in ALK-positive non-small cell lung cancers in the era of precision medicine
J. Remon, F. Tabbò, B. Jiménez, A. Collazo +2 more
2020Clinical and Translational Oncology7 citations
Semantic Scholar
Breakthrough cancer pain treatment in Spain: physicians’ perception of current opioids utilization and prescription
Francisco Villegas Estévez, M. D. López Alarcón, Alberto Alonso Babarro, Luis Olay Gayoso +3 more
2020Current Medical Research and Opinion6 citations Open access
Semantic Scholar
Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non–Small Cell Lung Cancer
B. Sierra-Rodero, Á. Gil-González, M. Molina-Alejandre, E. Nadal +26 more
2026Clinical Cancer Research5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Dómine×12
Invite
M. Dómine — researcher profile on SciRah
R. Bernabé×11
Invite
R. Bernabé — researcher profile on SciRah
A. Insa×11
Invite
A. Insa — researcher profile on SciRah
M. Provencio×10
Invite
M. Provencio — researcher profile on SciRah

×9

Invite

M. Majem — researcher profile on SciRah

Invite

E. Felip — researcher profile on SciRah

Invite

B. Massutí — researcher profile on SciRah

M. Provencio×8

Invite

M. Provencio — researcher profile on SciRah

C. Rodríguez-Antolín×8

Invite

C. Rodríguez-Antolín — researcher profile on SciRah

A. Martínez-Martí×7

Invite

A. Martínez-Martí — researcher profile on SciRah

Invite

V. Calvo — researcher profile on SciRah

D. Rodríguez-Abreu×7

Invite

D. Rodríguez-Abreu — researcher profile on SciRah